Polomar Health Services, Inc. 8-K

What Happened

• Polomar Health Services, Inc. announced it has mutually terminated the Agreement and Plan of Merger with Altanine, Inc. (the "Altanine Merger Agreement"), effective June 12, 2026. The original merger agreement was dated July 23, 2025 and had been amended once (First Amendment dated October 8, 2025). A proposed Second Amendment was never executed and is of no force or effect. The termination is documented in a Termination Agreement and Mutual Release filed as Exhibit 10.1 to the 8-K.

Key Details

• Termination effective date: June 12, 2026.
• Original merger agreement date: July 23, 2025; First Amendment: October 8, 2025.
• Related license terminated: the Know How and Patent License Agreement with Pinata Holdings, Inc. (a wholly owned Altanine subsidiary), originally dated June 29, 2024 and amended January 9, 2025, is terminated as of June 12, 2026.
• Polomar has until September 7, 2026 to sell, distribute or otherwise dispose of any remaining inventory or products developed or manufactured under the terminated patent/license agreement.

Why It Matters

• The filing removes the previously disclosed transaction that would have made Altanine a wholly owned subsidiary of Polomar, so the companies will not combine under the agreed terms.
• Termination of the patent/license agreement and the September 7, 2026 inventory disposal window set specific near-term operational steps and deadlines investors should watch for (inventory sales, product discontinuations, or related revenue impacts).
• Investors should monitor further disclosures (including any financial impacts, remaining obligations under the Termination Agreement, or new strategic plans) in future filings; the Termination Agreement is attached as Exhibit 10.1 for full terms.